IntegraGen, Assistance Publique - Hopitaux de Paris, Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Pa

IntegraGen received exclusive, worldwide rights from the hospital, institutes and university for IP covering use of the oncology biomarker hsa-miR-31-3p. The company said expression of the biomarker ...